ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 4ο | Seite 70

ΙSSN: 2623- 3673
Φεβρουάριος, 2019
Ψυχολογία :έρευνα & εφαρμογές
64. de Silva V, Suraweera C, Ratnatunga S, Dayabandara M, Wanniarachchi N,
Hanwella R. BMC Psychiatry. 2016 Oct 3;16(1):341. Metformin in prevention
and treatment of antipsychotic induced weight gain: a systematic review and
meta-analysis.
65. Vasudev K, Choi Y, Norman R, Kim R, Schwarz U. Can J Psychiatry. 2017
Feb;62(2):138-149. Genetic Determinants of Clozapine-Induced Metabolic Side
Effects.
66. Scarff J. Innov Clin Neurosci. 2016 Aug 1;13(7-8):26-9. Brexpiprazole: A
New Treatment Option for Schizophrenia.
67. Nasrallah H, Newcomer J, Risinger R, Du Y, Zummo J, Bose A, Stankovic
S, Silverman B, Ehrich E. J Clin Psychiatry. 2016 Nov;77(11):1519-1525 Effect
of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related
Safety Considerations Among Patients With Acute Schizophrenia.
68. Zimbron J, Khandaker G, Toschi C, Jones P, Fernandez-Egea E. Eur
Neuropsychopharmacol. 2016 Sep;26(9):1353-1365 A systematic review and
meta-analysis of randomised controlled trials of treatments for clozapine-induced
obesity and metabolic syndrome.
69. Franke R, Tarland E, Fink H, Pertz H, Brosda J. Psychopharmacology (Berl).
2016 Aug;233(15-16):3041-50. 2-Bromoterguride-a potential atypical
antipsychotic drug without metabolic effects in rats.
70. Siskind D, Leung J, Russell A, Wysoczanski D, Kisely S. PLoS One. 2016
Jun 15;11(6):e0156208. Metformin for Clozapine Associated Obesity: A
Systematic Review and Meta-Analysis.
71. Wang H, Woo Y, Bahk W. Int Clin Psychopharmacol. 2016 Nov;31(6):301-
6. The role of melatonin and melatonin agonists in counteracting antipsychotic-
induced metabolic side effects: a systematic review.
72. Kim N, Song Y, Kim E, Cho H, Cheon K, Kim SJ, Park J. Int Clin
Psychopharmacol. 2016 Sep;31(5):265-74. Adjunctive α-lipoic acid reduces
weight gain compared with placebo at 12 weeks in schizophrenic patients treated
with atypical antipsychotics: a double-blind randomized placebo-controlled
study.
73. Lui K, Randhawa G, Totten V, Smith A, Raese J. Prim Care Companion
CNS Disord. 2016 Jan 28;18(1). Is Metabolic Syndrome On the Radar?
Improving Real-Time Detection of Metabolic Syndrome and Physician Response
by Computerized Scan of the Electronic Medical Record.
74. Dudek M, Kuder K, Kołaczkowski M, Olczyk A, Żmudzka E, Rak A,
Bednarski M, Pytka K, Sapa J, Kieć-Kononowicz K. Metab Brain Dis. 2016
Oct;31(5):1023-9. H3 histamine receptor antagonist pitolisant reverses some
subchronic disturbances induced by olanzapine in mice.
75. Chen W, Huang W, Hsieh M. Schizophr Res. 2016 Jul;174(1-3):120-
125.Metformin-induced acute dystonia in a schizophrenic patient treated with
sulpiride and clozapine.
76. Kane J, Skuban A, Hobart M, Ouyang J, Weiller E, Weiss C, Correll C.
Schizophr Res. 2016 Jul;174(1-3):93-98..Overview of short- and long-term
tolerability and safety of brexpiprazole in patients with schizophrenia.